Brief: Advaxis Says Nasdaq Granted Extension To Regain Compliance With Minimum Bid Price Rule
11/08/2021 13:43
Aug 11 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS INC - NASDAQ GRANTS EXTENSION TO NOVEMBER 22,
2021, TO
REGAIN COMPLIANCE WITH $1.00 MINIMUM BID PRICE RULE
Source text for Eikon: ID:nGNX6KXFNz
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors